Robot hand coach lets patients rehab at home without a therapist
NCT ID NCT07182734
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a hand rehabilitation device called ReHandyBot, paired with a smartphone app called RehabCoach, can help people recover after a stroke, traumatic brain injury, or orthopedic problem. Thirty participants will first use the device under supervision at a clinic, then take it home for daily unsupervised therapy. The goal is to see if patients can use the tools safely and stick to their therapy schedule on their own.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ReHandyBot hand rehabilitation device and RehabCoach smartphone app
- What this could lead to
- If successful, this could show that home-based robotic therapy is safe and effective, potentially expanding rehab options for stroke, brain injury, and orthopedic patients.
- What could go wrong
- This is a small, early feasibility study with only 30 participants. It does not measure long-term recovery, and the device may not work well for everyone or may have technical issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2025
An estimate. Start dates often move.
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Eligibility criteria for neurological patients Inclusion criteria: * Informed Consent signed by the subject. * Female and male patients between 18 and 90 years old. * Stroke or traumatic brain injury (recruitment within 6 months from event onset). * Presence of a motor and/or sensory impairment of the upper limb as assessed by the responsible therapist. * Possibility (e.g., enough space) to set up the ReHandyBot at home. Exclusion criteria: * Modified Ashworth Scale \> 2 for one or more of the following muscles: shoulder adductors, forearm pronator and supinator, flexors and extensors of elbow, wrist and fingers. * Moderate to severe aphasia: Goodglass-Kaplan's scale \< 3. * Moderate to severe cognitive deficits: levels of cognitive functioning-revised (LCF-R) \< 9. * Functional impairment of the upper limb due to other pathologies. * Severe pain in the affected arm: visual analogue scale for pain (VASp) ≥ 5. * Other pathologies which may interfere with the study. * After discharge, the patient will go to an assisted living facility (e.g., care home). Eligibility criteria for orthopedic patients Inclusion criteria: * Informed Consent signed by the subject. * Female and male patients between 18 and 90 years old. * Clinic stay due to an orthopedic-related condition (e.g., surgery, trauma, burns). * Presence of a motor and/or sensory impairment of the upper limb as assessed by the responsible therapist. * Possibility (e.g., enough space) to set up the ReHandyBot at home. Exclusion criteria: * Moderate to severe aphasia: Goodglass-Kaplan's scale \< 3. * Moderate to severe cognitive deficits: levels of cognitive functioning-revised (LCF-R) \< 9. * Functional impairment of the upper limb due to other pathologies. * Severe pain in the affected arm: visual analogue scale for pain (VASp) ≥ 5. * Other pathologies which may interfere with the study. * After discharge, the patient will go to an assisted living facility (e.g., care home).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rehabilitation after neurological or orthopaedic injuries are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can group wellness classes improve life after brain injury or dementia?
- Can a web program rebuild memory after brain injury?
- Why a simple fall can cause brain bleeding in older adults
- Bedside ultrasound could flag hidden brain injury decline
- Zapping the brain to restore lost vision
- Can a laser light help stroke survivors steady their balance?